Amneal Pharmaceuticals, Inc.
NASDAQ:AMRX · NASDAQ Global Select
-$0.15 today
Vol 2.64M · Avg 1.75M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+107.29%
Period High
$16.34
Period Low
$7.82
Latest
$16.21
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Lantheus Holdings, Inc.
NASDAQ:LNTH
$6.79B
Mirum Pharmaceuticals, Inc.
NASDAQ:MIRM
$5.30B
Indivior Pharmaceuticals Inc
NASDAQ:INDV
$4.77B
Envista Holdings Corp
NYSE:NVST
$4.18B
Telix Pharmaceuticals Limited
NASDAQ:TLX
$3.39B
Dyne Therapeutics, Inc.
NASDAQ:DYN
$3.27B
Soleno Therapeutics, Inc.
SLNO
$2.76B
Supernus Pharmaceuticals, Inc.
NASDAQ:SUPN
$2.57B
Bausch Health Companies Inc.
NYSE:BHC
$1.74B
Perrigo Company plc
NYSE:PRGO
$1.37B
What is the latest AMRX filing?
The latest filing shown is 4 dated May 12, 2026.
How many recent filings does AMRX have?
Intrinsic Alpha currently shows 20 recent filings for AMRX.
Explore More
Continue the stock analysis
Jump to another research area for this company.